Medical Error and Technologies Research Workshop, London, 3 November 2004
Discussion points summary
v
Conducting
research into patient safety
Ø
Problems
of data collection and analysis
Ø
The
need for a theoretical framework
Ø
Different
theories of error. What
is an error?
Ø
Patient
perspective. Are patients represented in the research on
patient safety and medical errors? How should they be
involved?
Ø
Ethical
and legal issues of conducting research in the area of patient
safety. The tension between researchers’ duty to patients
and to the research subjects.
Ø
The
evolving role of ethic committees and their rules
v
Defining
errors
Ø
Different
types of errors. Problem areas (e.g. prescribing errors in
paediatrics).
Ø
What
is an error and what is ‘normal practice’. When does
variability of practice become an error? How is the definition
of error evolving?
Ø
What
are the attitudes to errors? Studies indicate that different
people (e.g. clinicians and pharmacists) pick up different
errors from notes. This suggests that different and
professional groups might define prescribing errors
differently.
Ø
Reporting
errors
Ø
Managing
errors and news about errors
v
Ethics,
law and society
Ø
Culture,
legal matters and litigation. The tension between the culture
of increased litigation and the aim of openness and ‘blame
free’ reporting. How is the culture changing and how might
it effect self-reporting of errors and the research in the
area?
Ø
Controversies
in prescription, regulation and use of certain drugs
v
‘Learning
organisations’
Ø
How
we can learn from each other? There is a need for feedback
Ø
How
errors should be reported and to whom?
v
Role
of pharmacists
Ø
New
reporting practices may change the way pharmacists are
perceived.
Ø
The
tension between pharmacists’ role as ‘part of the team’
and as ‘pharmacy police’
v
Computerised
systems
Ø
Advantages
and disadvantages
Ø
Specialised/bespoke
systems versus general systems. Tension between the need for
systems that respond to local needs and the need for
compatibility and universality of systems across the NHS
Ø
Design
of systems and electronic reporting.
Ø
Evaluation
of computerised systems. Different attitudes to evaluating
drugs, medical technology and information technology. It seems
that there is less emphasis on evaluating IT
v
The
implications of the
National Programme for Information Technology
|